Cure My Disease

Don't miss your cure!

 Log in / Sign up

Teen obesity study: does shedding pounds boost Post-Meal calorie burn?

NCT ID NCT07400159

Knowledge-focused Sponsor: Centre Hospitalier Emile Roux Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how weight loss affects the energy the body uses to digest food (called dietary thermogenesis) in teens with obesity. Researchers will compare 30 obese adolescents before and after weight loss with normal-weight teens. The goal is to understand if losing weight helps improve this calorie-burning process, which may play a role in managing obesity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Feb 2026

An estimate. Start dates often move.

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

11 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: • Adolescents aged 11 to 17 (inclusive), at Tanner stage 3-5 of sexual maturation, * With obesity defined by a Quételet index above the 97th percentile according to national curves for adolescents with obesity and a Quételet index classifying them as normal weight adolescents for the control group, * Adolescents affiliated with the social security system or equivalent, * Adolescent who has been informed and has given written consent to participate in the study. Exclusion Criteria: • Refusal to participate in the study, * Refusal of consent by legal guardians, * Regular consumption of tobacco or alcohol, * Special diet, * Participation in regular and intense physical and sporting activities, * Medical or surgical history deemed by the investigator to be incompatible with the study, * Presence of diabetes, and any other condition limiting the application of either strategy being tested, * Adolescents undergoing energy restriction or a weight loss program through physical activity at the time of inclusion or during the last 6 months, * Taking medication that may interfere with the study results. * Adolescents with cardiovascular problems, i.e., subjects with a history of cardiovascular and/or neurovascular disease, as well as subjects with cardiovascular and/or neurovascular risk factors (excluding obesity/overweight). * Surgery in the previous 3 months, * Adolescents who are currently excluded from another study, * Pregnant or breastfeeding adolescents, * Adolescents under guardianship/curatorship or legal protection, * Parents under guardianship/curatorship or legal protection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obesity / overweight are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obesity / overweight

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Laboratoire AME2P, Université Clermont Auvergne

    Aubière, 63170, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.